Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MM-111 |
Trade Name | |
Synonyms | MM 111|MM111 |
Drug Descriptions |
MM-111 is a bispecific antibody that binds simultaneously to ERBB2 (HER2) and ERBB3 (HER3) which may block signaling and inhibit tumor growth (PMID: 22248472, PMID: 30079142). |
DrugClasses | HER2 (ERBB2) Antibody 76 HER3 (ERBB3) Antibody 23 |
CAS Registry Number | 1361108-53-3 |
NCIT ID | C85486 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MM-111 | MM-111 | 0 | 0 |
MM-111 + Paclitaxel + Trastuzumab | MM-111 Paclitaxel Trastuzumab | 0 | 1 |